Trulieve Cannabis Corp.TRLVReports Thu, Nov 5 · Q3 2026
Health Care · Pharmaceuticals, Biotechnology & Life Sciences · NYSE · United States · trulieve.com
Trulieve Cannabis Corp. is a U.S. cannabis company headquartered in Tallahassee, Florida, that produces and sells medical and recreational cannabis products. In June 2026 it became the first U.S.-based cannabis company listed on the New York Stock Exchange, uplisting under the symbol TRLV following the federal rescheduling of medical marijuana to Schedule III.
Key ratios
Operating cash flow growth
51.2%TTM
2025
0.4%2024
31.1%2023
868.0%
FCF / Sales
19.4%2025
2024
12.6%2023
14.8%
Net margin
-6.9%TTM
2025
-9.9%2024
-13.1%2023
-46.7%
ROA
3.3%TTM
2025
3.3%2024
2.1%2023
1.9%
ROE
-6.9%TTM
2025
-9.8%2024
-11.7%2023
-26.1%
Revenue growth
-0.5%2025
2024
5.1%2023
-7.3%
Recent news
Trulieve Receives DEA Registrations for State-Licensed Medical Marijuana Operations
Trulieve Repays $65 Million Mortgage Strengthening Balance Sheet
Trulieve Cannabis Corp. to Hold Third Quarter 2026 Results Conference Call on November 5, 2026
Trulieve Announces Exclusive Master Licensing Agreement with Connected for Florida and Texas
Trulieve Cannabis Corp. Added to S&P Total Market and S&P Completion Indices
Trulieve to Open Medical Cannabis Dispensary in Dunwoody, Georgia
Trulieve Announces September 2026 Event Participation
Trulieve to Ring The Closing Bell at the New York Stock Exchange as First U.S. Cannabis Company Listed on the NYSE
Trulieve Completes Redomicile from British Columbia to Delaware
Trulieve Reports Second Quarter 2026 Results
Track TRLV in your journal
Save it to a watchlist, run a reverse DCF, and keep your notes on the company in one place. Free to start.
Figures are sourced from third parties and shown for research only. They may be delayed or incomplete, and nothing on this page is investment advice or a recommendation to buy or sell. Read the full disclaimer